Companies: 10,795·Total market cap: $144.5T
CARGO Therapeutics, Inc. Common Stock

CARGO Therapeutics, Inc. Common Stock

CRGXNASDAQHealthcare
$4.47
+$0.00(+0.00%)
Market Cap$216188421
P/E Ratio
52W High$25.45
52W Low$3
Overview

CARGO Therapeutics, Inc. Common Stock (CRGX) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · CRGX · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-4.68crgx eps ttm · crgx earnings per shareEarnings history
PE Ratio (TTM)crgx pe ratio ttm · crgx price to earningsPE Ratio deep dive
Revenue (TTM)$7.8Mcrgx revenue ttm · crgx annual revenueFull revenue history
Dividend YieldNo Dividenddoes crgx pay dividends · crgx dividend yieldDividend history
Shares Outstanding45.0Mcrgx shares outstanding · crgx floatShares outstanding history
Next EarningsTBAcrgx earnings date · crgx next earningsEarnings history

Financial Snapshot

Full Financials
FY 2024Revenue$0.00
202220232024
cargo therapeutics, inc. common stock revenue · crgx revenue 2024
FY 2024Net Income-$167.5M▼ 70.66% YoY
202220232024
cargo therapeutics, inc. common stock net income · crgx profit 2024
FY 2024EPS$-3.72▼ 56.30% YoY
202220232024
crgx eps · cargo therapeutics, inc. common stock earnings per share 2024
TTM:Revenue: $7.8MNet Income: -$221.8MEPS: $-4.68View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Hold7 analystsis crgx a buy · crgx analyst rating
Strong Buy
0
Buy
0
Hold
6
Sell
1
Strong Sell
0
12-Month Price Target
$7.00Low
$4.47Current
$23.00Avg Target414.54% upside
$34.00High
crgx price target · crgx 12 month forecast

Total: 7 · Buy rate: 0.0%

The CRGX analyst consensus is Hold, based on ratings from 7 Wall Street analysts over the past 3 months. The average 12-month price target is $23.00, representing +414.54% upside from the current price of $4.47.

Stock Performance

Full History
1D+0.00%
1W+0.00%
1M+0.00%
3M+2.76%
YTD-70.30%
1Y-81.53%
5Y-69.24%

About CARGO Therapeutics, Inc. Common Stock

CEOAnup Radhakrishnan
IPO DateNov 13, 2023
Employees167
CountryUS

CARGO Therapeutics, Inc. Common Stock CARGO Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to pioneering innovative chimeric antigen receptor (CAR) T-cell therapies for patients battling cancer. Its primary the…

what is cargo therapeutics, inc. common stock · crgx stock overview · cargo therapeutics, inc. common stock company profile · who is cargo therapeutics, inc. common stock ceo · crgx NASDAQ · cargo therapeutics, inc. common stock headquarters · cargo therapeutics, inc. common stock business segments

About Stock Overview & Key Data

CARGO Therapeutics, Inc. Common Stock (CRGX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Nov 13, 2023. As of the latest trading session, CRGX stock price is $4.47, with a market capitalization of $216.2M. The stock has returned -81.53% over the past 12 months and -70.30% year-to-date.

According to 7 Wall Street analysts, the consensus rating for CARGO Therapeutics, Inc. Common Stock stock is Hold, with an average 12-month price target of $23.00. In fiscal year 2024, CARGO Therapeutics, Inc. Common Stock reported revenue of — and net income of -$167.5M. For detailed data — including CARGO Therapeutics, Inc. Common Stock revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, CARGO Therapeutics, Inc. Common Stock (CRGX) stock price is $4.47. The stock is traded on NASDAQ under the ticker symbol CRGX. The 52-week range is $3.00 – $25.45.

CRGX stock priceCRGX quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice